Deborah Ashcraft

Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of <i>Bacteroides fragilis</i> Group, <i>Prevotella, Fusobacterium, Porphyromonas</i> , and <i>Peptostreptococcus</i> Species

Kenneth E. Aldridge, Deborah Ashcraft, K M Cambre et al. · Antimicrobial Agents and Chemotherapy · 2001 · 232 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +14

Detection of a New <i>cfr</i> -Like Gene, <i>cfr</i> (B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program

Lalitagauri M. Deshpande, Deborah Ashcraft, Heather P. Kahn et al. · Antimicrobial Agents and Chemotherapy · 2015 · 159 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Synergy of Daptomycin plus Rifampin against <i>Enterococcus faecium</i> Resistant to both Linezolid andVancomycin

George A. Pankey, Deborah Ashcraft, Nalini Patel · Antimicrobial Agents and Chemotherapy · 2005 · 82 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant <i>Pseudomonas aeruginosa</i>

George A. Pankey, Deborah Ashcraft · Antimicrobial Agents and Chemotherapy · 2005 · 79 citations

Life Sciences, Microbiology, Pharmacology +17

Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes

K E Aldridge, Deborah Ashcraft · Antimicrobial Agents and Chemotherapy · 1997 · 78 citations · Full text

Medicine, Microbiology, Pharmacology +8